OrbiMed Capital GP IV LLC, Director at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 81,305 shares at $320.00 ($26.0M) on 2014-04-09, disclosed to the SEC on 2014-04-11.
Open-market sale of $26.0M ICPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BOLD | SELL | 2018-03-12 | $10.2M | — | Filing → |
| BOLD | SELL | 2017-09-11 | $112K | — | Filing → |
| OTIC | SELL | 2015-11-24 | $5.7M | — | Filing → |